Thus, our these data revealed that similar to inhibition of ABCC1 with MK-571, knockdown of ABCC1 in breast cancer cells also promoted their increased retention of doxorubicin, consistent with a previous report on Jurkat cells [22]. The gene discussed is ABCC1; the disease is breast carcinoma.